Optima: A phase II dose and volume de-escalation trial for high and low-risk HPV + oropharynx cancers
10.1200/jco.2017.35.15_suppl.6066 · doi-reference
Diagnosis of HPV-driven head and neck cancer with a single test in routine clinical practice
10.1038/modpathol.2015.113 · doi-reference
Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment de-escalation trials
10.1093/annonc/mdt319 · doi-reference
Human papilloma virus testing in oropharyngeal squamous cell carcinoma: what the clinician should know
10.1016/j.oraloncology.2013.10.008 · doi-reference
Assessing head and neck cancer patient preferences and expectations: a systematic review
10.1016/j.oraloncology.2016.09.008 · doi-reference
Patient preferences for oropharyngeal cancer treatment deescalation
10.1002/hed.22930 · doi-reference
Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma
10.1002/cncr.26671 · doi-reference
Expanded application of selective neck dissection with regard to nodal status
10.1002/(sici)1097-0347(199707)19:4<260::aid-hed3>3.0.co;2-z · doi-reference
Efficacy of selective neck dissection: a review of 503 cases of elective and therapeutic treatment of the neck in squamous cell carcinoma of the upper aerodigestive tract
10.1067/mhn.2001.111598 · doi-reference
Robotic surgery for oropharynx cancer: promise, challenges and future directions
10.1007/s11912-012-0219-y · doi-reference
Transoral robotic surgery: a multicenter study to assess feasibility, safety, and surgical margins
10.1002/lary.23294 · doi-reference
